Kaufman Assessment Battery for Children | Second Edition Normative Update (KABC™-II NU) is a culturally fair ability test for all children. It is an effective and individually administered measure of cognitive ability. Guidance on using this test in your telepractice.
KABC-II NU Kit
Activate to view the image in zoom mode

Kaufman Assessment Battery for Children | Second Edition Normative Update

KABC-II NU

Kaufman Assessment Battery for Children | Second Edition Normative Update (KABC™-II NU) is a culturally fair ability test for all children. It is an effective and individually administered measure of cognitive ability. Guidance on using this test in your telepractice.
‹ View all tests and materials

KABC-II NU Advanced Use Live Webinar 3 Hours

A103000197873

Qualification Level

C

This 3-hour advanced training session provides in-depth analysis of KABC–II NU subtests, scales, and global indexes. Participants will learn how to use KABC-II NU results to identify and describe a pattern of cognitive strengths and weaknesses. Price includes up to 40 people per session.

Training orders will be processed within 5-7 business days of order placement. A training consultant will contact you to coordinate your training. Training dates are scheduled no earlier than 5 weeks from order placement.

$2,395.00

Audience: This session is targeted for experienced KABC–II NU users.

Course description: This 3-hour advanced training session provides an in-depth analysis of KABC–II NU subtests, scales, and global indexes. Participants will learn how to use KABC-II NU results to identify and describe a pattern of cognitive strengths and weaknesses.

Learning objectives: After attending this session, participants will be able to:

  • Apply the step-by-step interpretive approach to KABC–II NU profiles
  • Identify statistical and clinical significance of score differences between KABC–II NU scales
  • Show how to use KABC–II NU data to identify a pattern of cognitive strengths and weaknesses
  • Discuss interpretive considerations of KABC–II NU profiles for clinical groups